protein 3 Search Results


93
Elabscience Biotechnology human igfbp 3
Human Igfbp 3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/10__1590_slash_pboci__2024__047-66-27-30?v=Elabscience+Biotechnology
Average 93 stars, based on 1 article reviews
human igfbp 3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
OriGene h pdzrn3
H Pdzrn3, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pmc08742099-263-8-6?v=OriGene
Average 90 stars, based on 1 article reviews
h pdzrn3 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
Alomone Labs rabbit polyclonal anti sk3 antibody
CyPPA inhibits spontaneous and evoked release of dopamine form <t>TH/SK3</t> positive cultured rat midbrain neurons . (A) Western blot detection of SK3 in rat midbrain cultures. Extracts of HEK293 cells transiently transfected with rSK1, rSK2, and rSK3 and adult rat brain membranes (RBM) as well as lysates from cultured midbrain neurons were separated on 4–15% SDS-PAGE and immunoblotted with anti-SK3 antibody. A band of approximately 70 kDa was detected in midbrain cultures, RBM lysates, and HEK293 cells transfected with rSK3. This band was absent in lanes loaded with HEK293 cells expressing rSK1 and rSK2. (B) Immunodetection of SK3 subunits in rat midbrain cultures. Cultured midbrain neurons (8 days in vitro ) were double-labeled for SK3 and tyrosine hydroxylase (TH). In TH-positive dopaminergic neurons, the SK3 subunit displayed a primarily somatic–dendritic localization whereas little immunoreactivity was associated with axons (arrow). Scale bar 20 μm. (C) Basal release and stimulated release with 25 mM KCl or inhibited release with 30 μM Cd 2+ and with 1 μM TTX. (D) Basal release and stimulated release with 3 μM haloperidol and inhibited release with 10 μM quinpirole. Blue bars represent inhibited release with increasing concentrations of CyPPA (* P < 0.05, ** P < 0.01). The data presented are representative of three independent experiments.
Rabbit Polyclonal Anti Sk3 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pmc03278045-33-30-37?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
rabbit polyclonal anti sk3 antibody - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

95
Alomone Labs alomone labs trpc3 antibody
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Alomone Labs Trpc3 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/10__1523_slash_jneurosci__2294___13__2013-51-9-9?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
alomone labs trpc3 antibody - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

91
Cusabio csb e15885h
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Csb E15885h, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pm37238986-76-13-14?v=Cusabio
Average 91 stars, based on 1 article reviews
csb e15885h - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

95
Bio X Cell human pd 1 antibodies
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Human Pd 1 Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pm39937158-303-2-8?v=Bio+X+Cell
Average 95 stars, based on 1 article reviews
human pd 1 antibodies - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Proteintech anti dkk3
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Anti Dkk3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/bio_rxiv__2024__04__10__588813-195-36-37?v=Proteintech
Average 93 stars, based on 1 article reviews
anti dkk3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

96
Proteintech anti oct4
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Anti Oct4, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pm41839397-96-64-66?v=Proteintech
Average 96 stars, based on 1 article reviews
anti oct4 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

93
Proteintech anti arp3
Figure 1. Immunolocalization of <t>TRPC3</t> in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.
Anti Arp3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/10__1128_slash_mcb__01097___15-45-26-27?v=Proteintech
Average 93 stars, based on 1 article reviews
anti arp3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Proteintech sycp3 polyclonal antibody
Fig. 2. The variation of spermatogenic cell after DTMUV infection. (A-D) Nucleus stained by DAPI. (E-H) Sertoli cells stained by <t>SYCP3.</t> (I-L) Merge pictures of DAPI and WT1 staining. Ctl: control group, 2 dpi: 2 days post-infection, 4 dpi: 4 days post-infection, 8 dpi: 8 days post-infection. Scar bars =20 μm.
Sycp3 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pm39823839-66-3-8?v=Proteintech
Average 94 stars, based on 1 article reviews
sycp3 polyclonal antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Proteintech shc3
(A) Heatmap of RNA-Seqs. (B) Selection of potential miR-455-5p downstream genes. (C) Schematic diagram of luciferase <t>reporter-Shc3</t> 3’UTR constructs. (D) The outcomes of miR-455-5p overexpression on the luciferase activity in HTR8/SVneo cells transfected with the WT or MUT luciferase reporter constructs. (E) The effect of miR-455-5p inhibition and overexpression on Shc3 mRNA expression in HTR8/SVneo cells. (F) The level of Shc3 protein expression after miR-455-5p inhibition and overexpression in HTR8/SVneo. Data presented shows the average values ± standard deviation (**p < 0.01, *p < 0.05). The findings presented were obtained from a minimum of three independent experiments.
Shc3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pmc11723625-30-0-14?v=Proteintech
Average 93 stars, based on 1 article reviews
shc3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Proteintech fabp3
a UMAP plot displaying 14 identified cell types within the goat mammary glands. Cells are annotated and colored by type. Subsets of cell types including luminal, basal, fibroblast, immune, endothelial cell are labeled. b The percentages of −4W (red) and +1 W (blue) cells in each cell type are shown in a UMAP plot. c UMAP plots showing the expression of selected marker genes in four luminal subtypes. d Pseudotemporal trajectory analysis of scRNA-seq data of luminal secretory cells is shown in a UMAP plot. e Changes in the proportion of LumSecP and LumSec cells in luminal cell types were identified by scRNA-seq data at −4W and +1 W. n = 3 goats per group. f Representative images of tissue immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. g Bar plots exhibiting the percentage of ALDH1A3-positive cells in luminal cells (labeled by KRT18) in f . n = 15 sections per group. h Representative images of tissue immunofluorescence staining for <t>FABP3</t> (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. i Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in h . n = 20 sections per group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in e , g , i .
Fabp3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+3/pmc12749961-292-15-17?v=Proteintech
Average 93 stars, based on 1 article reviews
fabp3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


CyPPA inhibits spontaneous and evoked release of dopamine form TH/SK3 positive cultured rat midbrain neurons . (A) Western blot detection of SK3 in rat midbrain cultures. Extracts of HEK293 cells transiently transfected with rSK1, rSK2, and rSK3 and adult rat brain membranes (RBM) as well as lysates from cultured midbrain neurons were separated on 4–15% SDS-PAGE and immunoblotted with anti-SK3 antibody. A band of approximately 70 kDa was detected in midbrain cultures, RBM lysates, and HEK293 cells transfected with rSK3. This band was absent in lanes loaded with HEK293 cells expressing rSK1 and rSK2. (B) Immunodetection of SK3 subunits in rat midbrain cultures. Cultured midbrain neurons (8 days in vitro ) were double-labeled for SK3 and tyrosine hydroxylase (TH). In TH-positive dopaminergic neurons, the SK3 subunit displayed a primarily somatic–dendritic localization whereas little immunoreactivity was associated with axons (arrow). Scale bar 20 μm. (C) Basal release and stimulated release with 25 mM KCl or inhibited release with 30 μM Cd 2+ and with 1 μM TTX. (D) Basal release and stimulated release with 3 μM haloperidol and inhibited release with 10 μM quinpirole. Blue bars represent inhibited release with increasing concentrations of CyPPA (* P < 0.05, ** P < 0.01). The data presented are representative of three independent experiments.

Journal: Frontiers in Pharmacology

Article Title: CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate 1

doi: 10.3389/fphar.2012.00011

Figure Lengend Snippet: CyPPA inhibits spontaneous and evoked release of dopamine form TH/SK3 positive cultured rat midbrain neurons . (A) Western blot detection of SK3 in rat midbrain cultures. Extracts of HEK293 cells transiently transfected with rSK1, rSK2, and rSK3 and adult rat brain membranes (RBM) as well as lysates from cultured midbrain neurons were separated on 4–15% SDS-PAGE and immunoblotted with anti-SK3 antibody. A band of approximately 70 kDa was detected in midbrain cultures, RBM lysates, and HEK293 cells transfected with rSK3. This band was absent in lanes loaded with HEK293 cells expressing rSK1 and rSK2. (B) Immunodetection of SK3 subunits in rat midbrain cultures. Cultured midbrain neurons (8 days in vitro ) were double-labeled for SK3 and tyrosine hydroxylase (TH). In TH-positive dopaminergic neurons, the SK3 subunit displayed a primarily somatic–dendritic localization whereas little immunoreactivity was associated with axons (arrow). Scale bar 20 μm. (C) Basal release and stimulated release with 25 mM KCl or inhibited release with 30 μM Cd 2+ and with 1 μM TTX. (D) Basal release and stimulated release with 3 μM haloperidol and inhibited release with 10 μM quinpirole. Blue bars represent inhibited release with increasing concentrations of CyPPA (* P < 0.05, ** P < 0.01). The data presented are representative of three independent experiments.

Article Snippet: Neurobasal media and B-27 were obtained from Invitrogen (Nærum, Denmark) and 3 H-DA was acquired from PerkinElmer Life and Analytical Sciences (Boston, MA, USA) The primary antibodies used were a rabbit polyclonal anti-SK3 antibody (1:100, APC-025) from Alomone Labs (Jerusalem, Israel) and a monoclonal mouse anti-tyrosine hydroxylase antibody (1:150, clone LNC1) from Millipore (Copenhagen, Denmark).

Techniques: Cell Culture, Western Blot, Transfection, SDS Page, Expressing, Immunodetection, In Vitro, Labeling

Figure 1. Immunolocalization of TRPC3 in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.

Journal: Journal of Neuroscience

Article Title: Early Onset of Ataxia in Moonwalker Mice Is Accompanied by Complete Ablation of Type II Unipolar Brush Cells and Purkinje Cell Dysfunction

doi: 10.1523/jneurosci.2294-13.2013

Figure Lengend Snippet: Figure 1. Immunolocalization of TRPC3 in cerebellar paraffin sections from wild-type and TRPC3 / mice. A, Enrichment of TRPC3-immunoreactive UBCs in nodulus (X) and ventral uvula (folia IXb and IXc) in a wild-type mouse. Other lobules (IXa, VIII) contain few TRPC3- positive UBCs. PCs show only moderate immunostaining. B, Immunostained cells in nodulus show typical UBC morphology: mid-sized soma (arrow) and intensely immunoreactive brush (arrowhead). C–H, Confocal images from a wild-type mouse illustrate colocalization of TRPC3 with mGluR1 in type II UBCs (C–E). TRPC3 is absent from CR-positive type I UBCs (F–H). Arrowsandarrowheadsindicatesomataanddendriticbrushes,respectively(white,typeIIUBC; blue, type I UBCs). I, J, TRPC3 immunostaining is abolished in the cerebellar sections from a TRPC3/mouse(I);however,theimmunostainingofmGluR1intypeIIUBCs(arrowheads) and PCs (labeling in ml) appears unaffected (J). Asterisks indicate PC somata. ml, Molecular layer; gcl granule cell layer.

Article Snippet: PC immunoreactivity was apparent in cryosections labeled with the Alomone Labs TRPC3 antibody, whereas UBCs were barely labeled (data not shown).

Techniques: Immunostaining, Labeling

Figure 2. TRPC3 channels expressed in type II UBCs are functional. A, Time course of the current (at 70 mV) in control conditions and in the presence of DHPG and DHPGPyr3 in type II UBCs obtained from Tg(Grp-EGFP)DV197Gsat (control, black symbols,n 10)andTRPC3 /(redsymbols,n 5)mice.Currentswerenormalizedtothecontrolcurrent(averagedbetween 240and300s).Atotalof50MDHPGincreasedthecurrentupto2.5foldinUBCsfromcontrolmice.SubsequentapplicationofPyr3 (30 M), a TRPC3 antagonist, decreased the DHPG-sensitive currents by 54.5 10.6% (p 0.05, ANOVA with Newman–Keuls post hoc test). In type II UBCs of TRPC3 / mice, DHPG only induced a detectable current in three of five cells, and it was not blockedbyPyr3.B,VoltagerampusedtomeasurethePyr3-sensitivecurrentshowninCandD.C,D,RepresentativePyr3-sensitive currentsobtainedbydigitalsubtractionoftheaveragecurrentinDHPGandPyr3fromtheaveragecurrentinDHPG(markedascand b in A, respectively) in control mice (C) and TRPC3 / mice (D).

Journal: Journal of Neuroscience

Article Title: Early Onset of Ataxia in Moonwalker Mice Is Accompanied by Complete Ablation of Type II Unipolar Brush Cells and Purkinje Cell Dysfunction

doi: 10.1523/jneurosci.2294-13.2013

Figure Lengend Snippet: Figure 2. TRPC3 channels expressed in type II UBCs are functional. A, Time course of the current (at 70 mV) in control conditions and in the presence of DHPG and DHPGPyr3 in type II UBCs obtained from Tg(Grp-EGFP)DV197Gsat (control, black symbols,n 10)andTRPC3 /(redsymbols,n 5)mice.Currentswerenormalizedtothecontrolcurrent(averagedbetween 240and300s).Atotalof50MDHPGincreasedthecurrentupto2.5foldinUBCsfromcontrolmice.SubsequentapplicationofPyr3 (30 M), a TRPC3 antagonist, decreased the DHPG-sensitive currents by 54.5 10.6% (p 0.05, ANOVA with Newman–Keuls post hoc test). In type II UBCs of TRPC3 / mice, DHPG only induced a detectable current in three of five cells, and it was not blockedbyPyr3.B,VoltagerampusedtomeasurethePyr3-sensitivecurrentshowninCandD.C,D,RepresentativePyr3-sensitive currentsobtainedbydigitalsubtractionoftheaveragecurrentinDHPGandPyr3fromtheaveragecurrentinDHPG(markedascand b in A, respectively) in control mice (C) and TRPC3 / mice (D).

Article Snippet: PC immunoreactivity was apparent in cryosections labeled with the Alomone Labs TRPC3 antibody, whereas UBCs were barely labeled (data not shown).

Techniques: Functional Assay, Control

Fig. 2. The variation of spermatogenic cell after DTMUV infection. (A-D) Nucleus stained by DAPI. (E-H) Sertoli cells stained by SYCP3. (I-L) Merge pictures of DAPI and WT1 staining. Ctl: control group, 2 dpi: 2 days post-infection, 4 dpi: 4 days post-infection, 8 dpi: 8 days post-infection. Scar bars =20 μm.

Journal: Poultry science

Article Title: Duck Tembusu virus induced mitophagy in vacuolate spermatogenic cells is mediated by PINK1-Parkin pathway.

doi: 10.1016/j.psj.2025.104795

Figure Lengend Snippet: Fig. 2. The variation of spermatogenic cell after DTMUV infection. (A-D) Nucleus stained by DAPI. (E-H) Sertoli cells stained by SYCP3. (I-L) Merge pictures of DAPI and WT1 staining. Ctl: control group, 2 dpi: 2 days post-infection, 4 dpi: 4 days post-infection, 8 dpi: 8 days post-infection. Scar bars =20 μm.

Article Snippet: After incubation with SYCP3 Polyclonal antibody (1:200, 23024-1-AP, Proteintech, Wuhan) overnight at 4◦C, the sections were incubated via FITC-conjugated Goat anti-Rabbit IgG (H + L) (1:200, ABclonal, AS011, Wuhan) at 37◦C for 30 min.

Techniques: Infection, Staining, Control

(A) Heatmap of RNA-Seqs. (B) Selection of potential miR-455-5p downstream genes. (C) Schematic diagram of luciferase reporter-Shc3 3’UTR constructs. (D) The outcomes of miR-455-5p overexpression on the luciferase activity in HTR8/SVneo cells transfected with the WT or MUT luciferase reporter constructs. (E) The effect of miR-455-5p inhibition and overexpression on Shc3 mRNA expression in HTR8/SVneo cells. (F) The level of Shc3 protein expression after miR-455-5p inhibition and overexpression in HTR8/SVneo. Data presented shows the average values ± standard deviation (**p < 0.01, *p < 0.05). The findings presented were obtained from a minimum of three independent experiments.

Journal: PLOS ONE

Article Title: Short communication: Upregulation of hypoxia/reoxygenation-induced Shc3 by downregulated miR-455-5p, suppresses trophoblast invasion and is associated with placental inflammation and angiogenesis in preeclampsia

doi: 10.1371/journal.pone.0314544

Figure Lengend Snippet: (A) Heatmap of RNA-Seqs. (B) Selection of potential miR-455-5p downstream genes. (C) Schematic diagram of luciferase reporter-Shc3 3’UTR constructs. (D) The outcomes of miR-455-5p overexpression on the luciferase activity in HTR8/SVneo cells transfected with the WT or MUT luciferase reporter constructs. (E) The effect of miR-455-5p inhibition and overexpression on Shc3 mRNA expression in HTR8/SVneo cells. (F) The level of Shc3 protein expression after miR-455-5p inhibition and overexpression in HTR8/SVneo. Data presented shows the average values ± standard deviation (**p < 0.01, *p < 0.05). The findings presented were obtained from a minimum of three independent experiments.

Article Snippet: SHC3, Beta Actin antibodies and HRP-conjugated Affinipure Goat Anti Rabbit IgG(H+L) were obtained from Proteintech (Wuhan, China).

Techniques: Selection, Luciferase, Construct, Over Expression, Activity Assay, Transfection, Inhibition, Expressing, Standard Deviation

(A) The migration and invasion of HTR8/SVneo cells with miR-455-5p overexpression plasmids co-cultured with the plasmids of Shc3, or Shc3-NC in H/R. (B) Flow cytometry data of the apoptosis of HTR8/SVneo cells with miR-455-5p overexpression plasmids co-cultured with the plasmids expressing Shc3 or Shc3-NC in H/R. (C) Western blot results of Shc3 expression in HTR8/SVneo cells transfected with the miR-455-5p mimic, Shc3, or Shc3-NC. (D) The results of Shc3 expression examined by immunohistochemistry. Data presented indicate the average values ± standard deviation (**p < 0.01, *p < 0.05). The findings presented were obtained from a minimum of three independent experiments.

Journal: PLOS ONE

Article Title: Short communication: Upregulation of hypoxia/reoxygenation-induced Shc3 by downregulated miR-455-5p, suppresses trophoblast invasion and is associated with placental inflammation and angiogenesis in preeclampsia

doi: 10.1371/journal.pone.0314544

Figure Lengend Snippet: (A) The migration and invasion of HTR8/SVneo cells with miR-455-5p overexpression plasmids co-cultured with the plasmids of Shc3, or Shc3-NC in H/R. (B) Flow cytometry data of the apoptosis of HTR8/SVneo cells with miR-455-5p overexpression plasmids co-cultured with the plasmids expressing Shc3 or Shc3-NC in H/R. (C) Western blot results of Shc3 expression in HTR8/SVneo cells transfected with the miR-455-5p mimic, Shc3, or Shc3-NC. (D) The results of Shc3 expression examined by immunohistochemistry. Data presented indicate the average values ± standard deviation (**p < 0.01, *p < 0.05). The findings presented were obtained from a minimum of three independent experiments.

Article Snippet: SHC3, Beta Actin antibodies and HRP-conjugated Affinipure Goat Anti Rabbit IgG(H+L) were obtained from Proteintech (Wuhan, China).

Techniques: Migration, Over Expression, Cell Culture, Flow Cytometry, Expressing, Western Blot, Transfection, Immunohistochemistry, Standard Deviation

(A~B). H/R promotes the production of Shc3, which may be transported to the extracellular space through medium/large extracellular vesicles. (A) Western blot results of Shc3 expression in hypoxia, H/R, and normoxia, respectively. (B) Volcano plot of Shc3 mRNA expression in placental tissue, extracellular medium/large vesicles and small vesicles. (C~E). Shc3 is involved in placental inflammation and angiogenesis inhibition. (C) Hematoxylin-eosin staining results on normotensive placental tissues and high Shc3 expression PE placental tissues. (D) The level of Shc3 in EA.hy926 after transfection with the plasmids of Shc3, and Shc3-NC, in H/R compared with controls. (E) Angiogenesis of EA.hy926 after transfection with the plasmids of Shc3, and Shc3-NC in H/R, as determined by the number of master junction and master segment length.

Journal: PLOS ONE

Article Title: Short communication: Upregulation of hypoxia/reoxygenation-induced Shc3 by downregulated miR-455-5p, suppresses trophoblast invasion and is associated with placental inflammation and angiogenesis in preeclampsia

doi: 10.1371/journal.pone.0314544

Figure Lengend Snippet: (A~B). H/R promotes the production of Shc3, which may be transported to the extracellular space through medium/large extracellular vesicles. (A) Western blot results of Shc3 expression in hypoxia, H/R, and normoxia, respectively. (B) Volcano plot of Shc3 mRNA expression in placental tissue, extracellular medium/large vesicles and small vesicles. (C~E). Shc3 is involved in placental inflammation and angiogenesis inhibition. (C) Hematoxylin-eosin staining results on normotensive placental tissues and high Shc3 expression PE placental tissues. (D) The level of Shc3 in EA.hy926 after transfection with the plasmids of Shc3, and Shc3-NC, in H/R compared with controls. (E) Angiogenesis of EA.hy926 after transfection with the plasmids of Shc3, and Shc3-NC in H/R, as determined by the number of master junction and master segment length.

Article Snippet: SHC3, Beta Actin antibodies and HRP-conjugated Affinipure Goat Anti Rabbit IgG(H+L) were obtained from Proteintech (Wuhan, China).

Techniques: Western Blot, Expressing, Inhibition, Staining, Transfection

a UMAP plot displaying 14 identified cell types within the goat mammary glands. Cells are annotated and colored by type. Subsets of cell types including luminal, basal, fibroblast, immune, endothelial cell are labeled. b The percentages of −4W (red) and +1 W (blue) cells in each cell type are shown in a UMAP plot. c UMAP plots showing the expression of selected marker genes in four luminal subtypes. d Pseudotemporal trajectory analysis of scRNA-seq data of luminal secretory cells is shown in a UMAP plot. e Changes in the proportion of LumSecP and LumSec cells in luminal cell types were identified by scRNA-seq data at −4W and +1 W. n = 3 goats per group. f Representative images of tissue immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. g Bar plots exhibiting the percentage of ALDH1A3-positive cells in luminal cells (labeled by KRT18) in f . n = 15 sections per group. h Representative images of tissue immunofluorescence staining for FABP3 (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. i Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in h . n = 20 sections per group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in e , g , i .

Journal: Cell Discovery

Article Title: Luminal hormone-responsive cells tune the regenerative remodeling of mammary glands in large mammals

doi: 10.1038/s41421-025-00848-3

Figure Lengend Snippet: a UMAP plot displaying 14 identified cell types within the goat mammary glands. Cells are annotated and colored by type. Subsets of cell types including luminal, basal, fibroblast, immune, endothelial cell are labeled. b The percentages of −4W (red) and +1 W (blue) cells in each cell type are shown in a UMAP plot. c UMAP plots showing the expression of selected marker genes in four luminal subtypes. d Pseudotemporal trajectory analysis of scRNA-seq data of luminal secretory cells is shown in a UMAP plot. e Changes in the proportion of LumSecP and LumSec cells in luminal cell types were identified by scRNA-seq data at −4W and +1 W. n = 3 goats per group. f Representative images of tissue immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. g Bar plots exhibiting the percentage of ALDH1A3-positive cells in luminal cells (labeled by KRT18) in f . n = 15 sections per group. h Representative images of tissue immunofluorescence staining for FABP3 (red), KRT18 (green), and DAPI at −4W and +1 W. Scale bars, 50 μm. i Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in h . n = 20 sections per group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in e , g , i .

Article Snippet: For immunofluorescence staining, goat mammary tissues were stained with primary antibodies against ALDH1A3 (#25167-1-AP, Proteintech), FABP3 (#10676-1-AP, Proteintech), KRT17 (#17516-1-AP, Proteintech), KRT14 (#SC65-06, HUABIO), KRT18 (conjugated with iFluorTM 488, #SZ80-07, HUABIO), KRT8 (#10384-1-AP, ProteinTech), PR (#25871-1-AP, ProteinTech), ER (#21244-1-AP, ProteinTech), and PCNA (#ab29, Abcam).

Techniques: Labeling, Expressing, Marker, Immunofluorescence, Staining

a Relative proportions of LumHR cells in total luminal cells identified by scRNA-seq data at −4W and +1 W. n = 3 goats per group. b , c Bar plots exhibiting the percentage of PGR - and ESR1 -positive cells within luminal cells in scRNA-seq data. n = 3 goats per group. d Representative images of immunofluorescence staining for PR (red), KRT18 (green), and DAPI (blue). Scale bars, 50 μm. e Bar plots exhibiting the percentage of PR-positive cells in luminal cells (labeled by KRT18) in ( d ). n = 5 goats per group. f Representative images of immunofluorescence staining for ER (red), KRT18 (green), and DAPI (blue). Scale bars, 50 μm. g Bar plots exhibiting the percentage of ER-positive cells in luminal cells (labeled by KRT18) in ( f ). n = 5 goats. h Violin plot showing the specific expression of PRLR in LumHR cells by scRNA-seq. i Heatmap displaying the transcriptional level of indicated genes related to milk protein and luminal differentiation in the goat mammary organoids ( n = 3 biological replicates) treated with or without prolactin and in the mammary tissue at −4W (non-lactation) and +1 W (lactation). n = 3 goats for tissues. j Proportions of luminal cell types in goat mammary organoids incubated with or without prolactin predicted by CIBERSORTx deconvolution. n = 3 biological replicates. k Representative images of immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI in mammary organoids incubated with or without prolactin. Scale bars, 10 μm. l Bar plots exhibiting the percentage of ALDH1A3-positive cells in luminal cells (labeled by KRT18) in ( k ). n = 14 domes in the control group and n = 10 domes in the prolactin treated group. m Representative images of immunofluorescence staining for FABP3 (red), KRT18 (green) and DAPI in mammary organoids incubated with or without prolactin. Scale bars, 10 μm. n Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in ( m ). n = 6 domes in the control group and n = 7 domes in the prolactin-treated group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in ( a – c , e , g , j , l , n ).

Journal: Cell Discovery

Article Title: Luminal hormone-responsive cells tune the regenerative remodeling of mammary glands in large mammals

doi: 10.1038/s41421-025-00848-3

Figure Lengend Snippet: a Relative proportions of LumHR cells in total luminal cells identified by scRNA-seq data at −4W and +1 W. n = 3 goats per group. b , c Bar plots exhibiting the percentage of PGR - and ESR1 -positive cells within luminal cells in scRNA-seq data. n = 3 goats per group. d Representative images of immunofluorescence staining for PR (red), KRT18 (green), and DAPI (blue). Scale bars, 50 μm. e Bar plots exhibiting the percentage of PR-positive cells in luminal cells (labeled by KRT18) in ( d ). n = 5 goats per group. f Representative images of immunofluorescence staining for ER (red), KRT18 (green), and DAPI (blue). Scale bars, 50 μm. g Bar plots exhibiting the percentage of ER-positive cells in luminal cells (labeled by KRT18) in ( f ). n = 5 goats. h Violin plot showing the specific expression of PRLR in LumHR cells by scRNA-seq. i Heatmap displaying the transcriptional level of indicated genes related to milk protein and luminal differentiation in the goat mammary organoids ( n = 3 biological replicates) treated with or without prolactin and in the mammary tissue at −4W (non-lactation) and +1 W (lactation). n = 3 goats for tissues. j Proportions of luminal cell types in goat mammary organoids incubated with or without prolactin predicted by CIBERSORTx deconvolution. n = 3 biological replicates. k Representative images of immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI in mammary organoids incubated with or without prolactin. Scale bars, 10 μm. l Bar plots exhibiting the percentage of ALDH1A3-positive cells in luminal cells (labeled by KRT18) in ( k ). n = 14 domes in the control group and n = 10 domes in the prolactin treated group. m Representative images of immunofluorescence staining for FABP3 (red), KRT18 (green) and DAPI in mammary organoids incubated with or without prolactin. Scale bars, 10 μm. n Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in ( m ). n = 6 domes in the control group and n = 7 domes in the prolactin-treated group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in ( a – c , e , g , j , l , n ).

Article Snippet: For immunofluorescence staining, goat mammary tissues were stained with primary antibodies against ALDH1A3 (#25167-1-AP, Proteintech), FABP3 (#10676-1-AP, Proteintech), KRT17 (#17516-1-AP, Proteintech), KRT14 (#SC65-06, HUABIO), KRT18 (conjugated with iFluorTM 488, #SZ80-07, HUABIO), KRT8 (#10384-1-AP, ProteinTech), PR (#25871-1-AP, ProteinTech), ER (#21244-1-AP, ProteinTech), and PCNA (#ab29, Abcam).

Techniques: Immunofluorescence, Staining, Labeling, Expressing, Incubation, Control

a Schematic illustration of targeted ablation of LumHR cells using the prlr -promoter to drive expression of DTA. b Experimental setup used in AAV intraductally injected mammary gland of ROSA-DTA +/ − mice under RR. c Whole-mount staining with carmine alum of mammary glands from ROSA-DTA +/ − mice (lactation day 2) intraductally injected with AAV-pPrlr-Cre or AAV-Control . Scale bars, 4 mm (top) and 500 μm (bottom). d , e Immunohistochemical staining and quantification of ER-positive luminal cells in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control. n = 3 mice per group. Scale bars, 50 μm. f , g Immunohistochemical staining and quantification of PR-positive luminal cells in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . n = 3 mice per group. Scale bars, 50 μm. h , i Immunohistochemical staining and quantification of β-casein-positive alveoli number per mm 2 in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . n = 3 mice per group. Scale bars, 50 μm. j Representative images of immunofluorescence staining for FABP3 (red), KRT18 (green), and DAPI in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . Scale bars, 50 μm. k Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in j . n = 3 mice per group. l Representative images of immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Contro l. Scale bars, 50 μm. m Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in ( l ). n = 3 mice per group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in d , g , i , l , m .

Journal: Cell Discovery

Article Title: Luminal hormone-responsive cells tune the regenerative remodeling of mammary glands in large mammals

doi: 10.1038/s41421-025-00848-3

Figure Lengend Snippet: a Schematic illustration of targeted ablation of LumHR cells using the prlr -promoter to drive expression of DTA. b Experimental setup used in AAV intraductally injected mammary gland of ROSA-DTA +/ − mice under RR. c Whole-mount staining with carmine alum of mammary glands from ROSA-DTA +/ − mice (lactation day 2) intraductally injected with AAV-pPrlr-Cre or AAV-Control . Scale bars, 4 mm (top) and 500 μm (bottom). d , e Immunohistochemical staining and quantification of ER-positive luminal cells in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control. n = 3 mice per group. Scale bars, 50 μm. f , g Immunohistochemical staining and quantification of PR-positive luminal cells in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . n = 3 mice per group. Scale bars, 50 μm. h , i Immunohistochemical staining and quantification of β-casein-positive alveoli number per mm 2 in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . n = 3 mice per group. Scale bars, 50 μm. j Representative images of immunofluorescence staining for FABP3 (red), KRT18 (green), and DAPI in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Control . Scale bars, 50 μm. k Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in j . n = 3 mice per group. l Representative images of immunofluorescence staining for ALDH1A3 (red), KRT18 (green), and DAPI in mammary glands intraductally injected with AAV-pPrlr-Cre or AAV-Contro l. Scale bars, 50 μm. m Bar plots exhibiting the percentage of FABP3-positive cells in luminal cells (labeled by KRT18) in ( l ). n = 3 mice per group. The data are presented as the mean ± SEM. The P values of two-sided Student’s t -tests are shown in d , g , i , l , m .

Article Snippet: For immunofluorescence staining, goat mammary tissues were stained with primary antibodies against ALDH1A3 (#25167-1-AP, Proteintech), FABP3 (#10676-1-AP, Proteintech), KRT17 (#17516-1-AP, Proteintech), KRT14 (#SC65-06, HUABIO), KRT18 (conjugated with iFluorTM 488, #SZ80-07, HUABIO), KRT8 (#10384-1-AP, ProteinTech), PR (#25871-1-AP, ProteinTech), ER (#21244-1-AP, ProteinTech), and PCNA (#ab29, Abcam).

Techniques: Expressing, Injection, Staining, Control, Immunohistochemical staining, Immunofluorescence, Labeling